Literature DB >> 30553058

Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.

Qiuhong Rao1, Zhenwen Qiu1, Deen Huang2, Tiejun Lu3, Zhenyu Jason Zhang3, Dandong Luo1, Piaopiao Pan2, Lei Zhang2, Yingyan Liu4, Shixia Guan5, Qingguo Li6.   

Abstract

The ability to increase the bioavailability and dissolution of poorly soluble hydrophobic drugs has been a major challenge for pharmaceutical development. This study shows that the dissolution rate, apparent solubility and oral bioavailability of tadalafil (Td) can be improved by nano-sized amorphous particles prepared by using antisolvent precipitation. Acetone and an acetone-water solution (v:v, 9:1) were selected as solvents, with deionized water as the antisolvent. The antisolvent precipitation process was conducted at a constant drug concentration of 10 mg/ml, at temperatures of 5, 10 and 15 °C and at volume ratios of antisolvent to solvent (AS/S) of 5, 8 and 10. Solid dispersion was achieved by dissolving the polymer in the antisolvent prior to the precipitation and by spray drying the suspension after the antisolvent precipitation process. The selected polymers were HPMC, VA64, and PVPK30 at concentrations of 33, 100 and 300 mg per 100 ml of water (equivalent to weight ratios of drug-to-polymer of 1:3, 1:1 and 3:1, respectively). The solid dispersions were characterized by scanning electron microscopy (SEM), X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) and fourier transform infrared spectroscopy (FT-IR). The improvements in the dissolution rate, equilibrium solubility, apparent solubility and bioavailability were tested and compared with unprocessed Td. Td particles in the suspension (before spray drying) were 200 nm, and the obtained Td solid dispersion had a size of approximately 5-10 μm. The XRPD, DSC and FT-IR analyses confirmed that the prepared Td particles in the solid dispersions were amorphous. The solid dispersion obtained using the optimized process conditions exhibited 8.5 times faster dissolution rates in the first minute of dissolution, 22 times greater apparent solubility at 10 min and a 3.67-fold increase in oral bioavailability than the as-received Td. The present work demonstrated that low temperature antisolvent precipitation technique has excellent potential to prepare nano-sized amorphous particles with a faster release and a higher bioavailability.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Amorphous solid dispersion; Antisolvent precipitation; Apparent solubility; Bioavailability; Tadalafil

Mesh:

Substances:

Year:  2018        PMID: 30553058     DOI: 10.1016/j.ejps.2018.12.005

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  5 in total

Review 1.  Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.

Authors:  Rahul Kumar; Amit K Thakur; Nilanjana Banerjee; Ashutosh Kumar; Gajendra Kumar Gaurav; Raj Kumar Arya
Journal:  Drug Deliv Transl Res       Date:  2022-08-11       Impact factor: 5.671

Review 2.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

Review 3.  Supercritical fluid technology for solubilization of poorly water soluble drugs via micro- and naonosized particle generation.

Authors:  Shashi Kiran Misra; Kamla Pathak
Journal:  ADMET DMPK       Date:  2020-06-29

4.  A numerical approach to determine the optimal condition of the gas anti-solvent supercritical process for nanoparticles production.

Authors:  Nedasadat Saadati Ardestani; Mitra Amani
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

5.  Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease.

Authors:  Qun Wang; Rui Ma; Piaoxue Liu; Guowang Cheng; Qi Yang; Xiaojia Chen; Zhenfeng Wu; Dongsheng Yuan; Tongkai Chen
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.